Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA
OSA, Apoplexy
About this trial
This is an interventional treatment trial for OSA focused on measuring OSA, Apoplexy, CPAP, adherence, telemonitoring
Eligibility Criteria
Inclusion Criteria:
- s/p ACM (Arteria Cerebri Media Insult)
- Diagnosed OSA AHI >15/h
- Barthel Index item 8 > 5 points (or home assistance)
- Life expectancy >6 month
- Capable of giving consent
Exclusion Criteria:
- Already existing ventilatory support (CPAP, NIV etc)
- Central AI >50% baseline
- Central AI >5/h under CPAP therapy
- Drug abuse
- Pregnant or nursing women
- Participation in another clinical trial last 4 weeks
Sites / Locations
- Helios Klinik Hagen
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Unattended CPAP therapy
Telemonitoring and support
Therapy data will be examined by reading out the CPAP device after 6 months. Patients can obtain help on own request, corresponding to the standard CPAP prescription routine.
CPAP device therapy data will be downloaded by the study site via GSM modules once a week. In case of poor therapy adherence (defined by a minimum average usage of 3h/night over the week) a contact call will be initiated to motivate patients or solve problems identified by telemonitoring. If active home intervention is required, the study site will inform the healthcare provider to visit the patient in a timely manner.